Cancer Medication recalls
The FDA has published 42 recalls involving cancer medication since 2014. The latest was reported on 18 Feb 2026. Most were for packaging defects. Attix Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls42since 2014
Last 12 months3reported
Class I00% of total
Ongoing4latest 18 Feb 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 40 95%Class III 2 5%
Why cancer medication is recalled
Companies
Brands
By year
Ongoing cancer medication recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet recalled | F.H. INVESTMENTS, Inc. ( | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet recalled | F.H. INVESTMENTS, Inc. ( | Particulate Matter | Nationwide |
| Drug | CLASS II | Testosterone 100mg, Anastrozole 4mg 5), 1 Sterile Pellet recalled | F.H. INVESTMENTS, Inc. ( | Particulate Matter | Nationwide |
| Drug | CLASS III | Methotrexate Tablets, USP, 5 mg, Unit-Dose Tablets recalledMethotrexate Sodium | West-Ward Columbus | Other | MS, OH |
All cancer medication recalls, newest first
42 totalShould you stop taking Cancer Medication?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.